Genetic Testing Company, Principals Agree to Pay $42.6 Million

October 21, 2019

UTC Laboratories Inc. (RenRX) has agreed to pay $41.6 million and its three principals have agreed to pay $1 million to resolve allegations that they violated the False Claims Act by paying kickbacks in exchange for laboratory referrals for pharmacogenetic testing and for furnishing and billing for tests that were not medically necessary. The government alleged that between 2013 and 2017, UTC and its principals offered and paid remuneration to physicians to induce the ordering of pharmacogenetic tests, purportedly in return for their participation in a clinical trial known as the Diagnosing Adverse Drug Reactions Registry (DART). Read a news story. Read a Department of Justice press release
FindFind Help in Your State